COVID-19 Impact

You may see some delays in posting new content due to COVID-19. If you have any questions, please submit a message to PSNet Support.

PSNet: Patient Safety Network
Web Resource
Government Resource

Assessing the National Electronic Injury Surveillance System—Cooperative Adverse Drug Event Surveillance Project—six sites, United States, January 1–June 15, 2004.

Prevention C for DC and. MMWR. Morbidity and mortality weekly report. 2005;54:380-3.

The Centers for Disease Control (CDC), the Consumer Product Safety Commission (CPSC), and the Food and Drug Administration (FDA) collaboratively created this surveillance project to estimate incidence of adverse drug events. The summary describes the evaluation of the system, based on studying reports from a convenience sample of participating hospitals. While the sensitivity of capturing events was low, the positive predictive value that reported events represented in actual cases was high. An editorial note suggests that this reporting system may represent an important, ongoing resource for recording and preventing future adverse drug events.